Comparison of medication utilization in persons with cystic fibrosis seen and not seen by a cystic fibrosis-gastrointestinal clinic for constipation. by Nicha Wongjarupong (4671181)

Decrease in deviation of total land use percentage from city-supplied datasets with increasing sample size. by Christoph D. D. Rupprecht (579916)

Increase of Viral Dose and Addition of Mosquito Salivary Gland Extracts (SGE) Decrease circulating Viral RNA. by Anne M. Wertheimer (359266)

Tetanus seroprotection by province and age among children 6–59 months old in the EDS-RDC II. by Alvan Cheng (6733943)

The phsophorylation of the Dnmt1 at S127 and/orS143 decrease the capacity of the protein to interact with PCNA and UHRF1. by Eric Hervouet (246599)

Decrease of SRBC-specific antibody responses after <i>P</i>. <i>yoelii</i> infection. by Simran Banga (227952)

Detailed prevalence data from gnomAD [24] for ACE2 variants reported in Table 1. by Stuart A. MacGowan (11326845)

Subjects:

The structure of ACE2 (green) gnomAD [24] missense variant p.Lys26Arg that enhances Spike (light blue) binding affinity. by Stuart A. MacGowan (11326845)

Subjects:

Structural description of the ACE2 –Spike-protein interface. by Stuart A. MacGowan (11326845)

Subjects:

mCSM-PPI2 predicted ΔΔG with and without recalibration are in agreement with published deep mutagenesis binding data [22] at low predicted ΔΔG but recalibrated predictions are more... by Stuart A. MacGowan (11326845)

Subjects:

Estimated allele frequencies of potential novel variants in ACE2 with predicted Spike binding phenotypes. by Stuart A. MacGowan (11326845)

Subjects:

mCSM-PPI2 predictions for all gnomAD ACE2 missense variants in residues resolved in PDB 6vw1. by Stuart A. MacGowan (11326845)

Subjects:

Distribution of mCSM-PPI2 [13] predicted ΔΔG from in silico saturation mutagenesis of the ACE2-S interface in PDB 6vw1 [11]. by Stuart A. MacGowan (11326845)

Subjects:

Surface plasmon resonance derived ΔΔG and mCSM-PPI2 [13] predictions for ACE2 mutants, including gnomAD [24] missense variants, at or near the ACE2 Spike interface. by Stuart A. MacGowan (11326845)

Subjects:

The relationship between experimental and predicted ΔΔG of ACE2 mutants and relative SARS-CoV-2 pseudotype infectivity reported by Shukla et al [38]. by Stuart A. MacGowan (11326845)

Subjects:

The structure of ACE2 (green) gnomAD [24] missense variant p.Ser19Pro that enhances Spike (light blue) binding affinity. by Stuart A. MacGowan (11326845)

Subjects:

Binding affinity determination of ACE2 variants with SARS-CoV-2 Spike. by Stuart A. MacGowan (11326845)

Subjects:

Covid Host Genetics Initiative [31] Release 3 (accessed: 12^th October 2020) summaries for p.Lys26Arg (rs4646116). by Stuart A. MacGowan (11326845)

Subjects:

Different Association of Human Papillomavirus 16 Variants with Early and Late Presentation of Cervical Cancer by Ana Alfaro (280118)

“…Interestingly, when analyzing only the HPV16-positive CC, D2 increases (OR = 2.5, 95% CI = 1.2–5, p < 0.05) and D3 decreases (OR = 0.45, 95% CI 0.2–0.9, p < 0.05) the risk to develop CC before 50 years old in relation with A1/2 variant. …”

Mean of the difference between the RV-GLS value of the expert and trainees in four consecutive groups of 25 fetal heart clips. by Chantelle M. de Vet (16535257)